Application in addition to total mesorectal excision of transanal endoscopic surgery approach_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

LUO Shuangling ,  KANG Liang

Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510655, P. R. China;

Corresponding author：

KANG Liang, Email: kangl@mail.sysu.edu.cn

Keywords：

transanal endoscopic surgery; transanal total mesorectal excision

DOI：

10.7507/1007-9424.202311037

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

After more than 10 years of development, transanal total mesorectal excision (taTME) has played an important role in anus-preserving surgery for low rectal cancer. Existing studies have shown that taTME is not significantly different from traditional laparoscopy in the short-term and long-term efficacy of the treatment of low rectal cancer, and that taTME has potential advantages in postoperative functional recovery. With the maturity of taTME technology, transanal endoscopic approach has gradually been clinically applied to other rectal tumors, anastomotic stenosis, lateral lymph node dissection and other scenarios. Clinical practice shows that the transanal endoscopic approach can dissect pelvic tissues more accurately, greatly reduce the difficulty of surgery for complex pelvic diseases, improve the safety of surgery, and provide new ideas for clinical practice.

Citation： LUO Shuangling, KANG Liang. Application in addition to total mesorectal excision of transanal endoscopic surgery approach. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2023, 30(12): 1415-1420. doi: 10.7507/1007-9424.202311037 Copy

1.	Heald RJ. A new solution to some old problems: transanal TME. Tech Coloproctol, 2013, 17(3): 257-258.
2.	Sylla P, Rattner DW, Delgado S, et al. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc, 2010, 24(5): 1205-1210.
3.	de Lacy FB, van Laarhoven JJEM, Pena R, et al. Transanal total mesorectal excision: pathological results of 186 patients with mid and low rectal cancer. Surg Endosc, 2018, 32(5): 2442-2447.
4.	Aubert M, Mege D, Panis Y. Total mesorectal excision for low and middle rectal cancer: laparoscopic versus transanal approach-a meta-analysis. Surg Endosc, 2020, 34(9): 3908-3919.
5.	D’Andrea AP, McLemore EC, Bonaccorso A, et al. Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve. Surg Endosc, 2020, 34(9): 4101-4109.
6.	Gardner IH, Kelley KA, Abdelmoaty WF, et al. Transanal total mesorectal excision outcomes for advanced rectal cancer in a complex surgical population. Surg Endosc, 2022, 36(1): 167-175.
7.	Liu H, Zeng Z, Zhang H, et al. Morbidity, Mortality, and pathologic outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer short-term outcomes from a multicenter randomized controlled trial. Ann Surg, 2023, 277(1): 1-6.
8.	Benson AB, Venook AP, Al-Hawary MM, et al. Rectal Cancer, Version 2. 2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 2022, 20(10): 1139-1167.
9.	Buess G, Kipfmüller K, Ibald R, et al. Clinical results of transanal endoscopic microsurgery. Surg Endosc, 1988, 2(4): 245-250.
10.	Guerrieri M, Baldarelli M, de Sanctis A, et al. Treatment of rectal adenomas by transanal endoscopic microsurgery: 15 years' experience. Surg Endosc, 2010, 24(2): 445-449.
11.	Junginger T, Goenner U, Hitzler M, et al. Long-term oncologic outcome after transanal endoscopic microsurgery for rectal carcinoma. Dis Colon Rectum, 2016, 59(1): 8-15.
12.	Serra-Aracil X, Flores-Clotet R, Mora-López L, et al. Transanal endoscopic microsurgery in very large and ultra large rectal neoplasia. Tech Coloproctol, 2019, 23(9): 869-876.
13.	Khoury R, Duek SD, Issa N, et al. Transanal endoscopic microsurgery for large benign rectal tumors; where are the limits? Int J Surg, 2016, 29: 128-131.
14.	Atallah S, Larach SW. Transanal minimally invasive surgery. JAMA Surg, 2021, 156(1): 92-93.
15.	Lee L, Burke JP, deBeche-Adams T, et al. Transanal minimally invasive surgery for local excision of benign and malignant rectal neoplasia: outcomes from 200 consecutive cases with midterm follow up. Ann Surg, 2018, 267(5): 910-916.
16.	Lee L, Edwards K, Hunter IA, et al. Quality of local excision for rectal neoplasms using transanal endoscopic microsurgery versus transanal minimally invasive surgery: A multi-institutional matched analysis. Dis Colon Rectum, 2017, 60(9): 928-935.
17.	Stipa F, Tierno SM, Russo G, et al. Trans-anal minimally invasive surgery (TAMIS) versus trans-anal endoscopic microsurgery (TEM): a comparative case-control matched-pairs analysis. Surg Endosc, 2022, 36(3): 2081-2086.
18.	Van den Eynde F, Jaekers J, Fieuws S, et al. TAMIS is a valuable alternative to TEM for resection of intraluminal rectal tumors. Tech Coloproctol, 2019, 23(2): 161-166.
19.	Rindi G, Mete O, Uccella S, et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol, 2022, 33(1): 115-154.
20.	Shi WK, Hou R, Li YH, et al. Long-term outcomes of transanal endoscopic microsurgery for the treatment of rectal neuroendocrine tumors. BMC Surg, 2022, 22(1): 43.
21.	Lie JJ, Yoon HM, Karimuddin AA, et al. Management of rectal neuroendocrine tumours by transanal endoscopic microsurgery. Colorectal Dis, 2023, 25(5): 1026-1035.
22.	Park SS, Kim BC, Lee DE, et al. Comparison of endoscopic submucosal dissection and transanal endoscopic microsurgery for T1 rectal neuroendocrine tumors: a propensity score-matched study. Gastrointest Endosc, 2021, 94(2): 408-415.
23.	Hayashi S, Takayama T, Ikarashi M, et al. Transanal minimally invasive surgery for rectal neuroendocrine tumors. Surg Endosc, 2021, 35(12): 6746-6753.
24.	Kameyama H, Kanda T, Tajima Y, et al. Management of rectal gastrointestinal stromal tumor. Transl Gastroenterol Hepatol, 2018, 3: 8.
25.	Bai X, Zhou W, Li Y, et al. Transanal endoscopic microsurgery with alternative neoadjuvant imatinib for localized rectal gastrointestinal stromal tumor: a single center experience with long-term surveillance. Surg Endosc, 2021, 35(7): 3607-3617.
26.	Punnen S, Karimuddin AA, Raval MJ, et al. Transanal endoscopic microsurgery (TEM) for rectal GI stromal tumor. Am J Surg, 2021, 221(1): 183-186.
27.	Yang Z, Guo W, Huang R, et al. Transanal versus nontransanal surgery for the treatment of primary rectal gastrointestinal stromal tumors: a 10-year experience in a high-volume center. Ann Transl Med, 2020, 8(5): 201.
28.	Spinelli A, Carvello M, Sacchi M, et al. Transanal minimally invasive surgery (TAMIS) for anterior rectal GIST. Tech Coloproctol, 2019, 23(5): 501-502.
29.	Kato K, Saito T, Matsuda M, et al. Successful treatment of a rectal anastomotic stenosis by transanal endoscopic microsurgery (TEM) using the contact Nd: YAG laser. Surg Endosc, 1997, 11(5): 485-487.
30.	D’Ambrosio G, Lamazza A, Palma R, et al. Transanal endoscopic microsurgery: endoscopy assisted treatment of colorectal anastomotic stenosis. Ann Coloproctol, 2020, 36(4): 285-288.
31.	Valdés-Hernández J, Del Rio FJ, Gómez-Rosado JC, et al. TAMIS repair of a rectal stenosis not treatable by endoscopy. Tech Coloproctol, 2018, 22(11): 891.
32.	Dapri G, Van Gossum M, Muls V, et al. Transanal endo-laparoscopic circumferential mucosectomy for symptomatic benign rectal stenosis—a video vignette. Colorectal Dis, 2017, 19(2): 210-211.
33.	Zhou W, Xia L, Wang Z, et al. Transanal minimally invasive surgery for rectal anastomotic stenosis after colorectal cancer surgery. Dis Colon Rectum, 2022, 65(8): 1062-1068.
34.	Luo S, Zhang X, Hou Y, et al. Transanal and transabdominal combined endoscopic resection of rectal stenosis and anal reconstruction based on transanal endoscopic technique. Surg Endosc, 2021, 35(12): 6827-6835.
35.	Wang HT, Gao XH, Fu CG, et al. Diagnosis and treatment of diffuse cavernous hemangioma of the rectum: report of 17 cases. World J Surg, 2010, 34(10): 2477-2486.
36.	Wang HT, Tu Y, Fu CG, et al. Diffuse cavernous hemangioma of the rectosigmoid colon. Tech Coloproctol, 2005, 9(2): 145-148.
37.	Yorozuya K, Watanabe M, Hasegawa H, et al. Diffuse cavernous hemangioma of the rectum: report of a case. Surg Today, 2003, 33(4): 309-311.
38.	Londono-Schimmer EE, Ritchie JK, Hawley PR. Coloanal sleeve anastomosis in the treatment of diffuse cavernous haemangioma of the rectum: long-term results. Br J Surg, 1994, 81(8): 1235-1237.
39.	Wu XR, Liang WW, Zhang XW, et al. Transanal total mesorectal excision as a surgical procedure for diffuse cavernous hemangioma of the rectum: A case report. Int J Surg Case Rep, 2017, 39: 164-167.
40.	Zeng Z, Wu X, Chen J, et al. Safety and feasibility of transanal endoscopic surgery for diffuse cavernous hemangioma of the rectum. Gastroenterol Res Pract, 2019, 2019: 1732340.
41.	Truong A, Wood T, Fleshner PR, et al. A single-center experience of transanal proctectomy with IPAA for IBD. Dis Colon Rectum, 2022, 65(9): 1121-1128.
42.	de Buck van Overstraeten A, Mark-Christensen A, Wasmann KA, et al. Transanal versus transabdominal minimally invasive (completion) proctectomy with ileal pouch-anal anastomosis in ulcerative colitis: A comparative study. Ann Surg, 2017, 266(5): 878-883.
43.	中国医师协会内镜医师分会腹腔镜外科专业委员会, 中国医师协会结直肠肿瘤专业委员会腹腔镜专业委员会, 中华医学会外科学分会结直肠外科学组. 中国直肠癌侧方淋巴结转移诊疗专家共识(2019版). 中华胃肠外科杂志, 2019, 22(10): 901-912.
44.	Ogura A, Konishi T, Cunningham C, et al. Neoadjuvant (Chemo) radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: Results of the multicenter lateral node study of patients with low cT3/4 rectal cancer. J Clin Oncol, 2019, 37(1): 33-43.
45.	Aiba T, Uehara K, Mukai T, et al. Transanal extended rectal surgery with lateral pelvic lymph node dissection. Tech Coloproctol, 2018, 22(11): 893-894.
46.	Matsuda T, Yamashita K, Hasegawa H, et al. Two-team lateral pelvic lymph node dissection assisted by the transanal approach. Dis Colon Rectum, 2021, 64(12): e719-e724.
47.	曾子威, 张兴伟, 陈俊辑, 等. 经肛入路侧方淋巴结清扫手术治疗中低位直肠癌五例. 中华胃肠外科杂志, 2019, 22(8): 781-785.
48.	Kimura K, Ikeda M, Kataoka K, et al. Sacrectomy for recurrent rectal cancer using the transanal total mesorectum excision technique. Dis Colon Rectum, 2020, 63(12): e566-e573.
49.	Huang L, Zhang X, Zeng Z, et al. Pure transanal endoscopic colectomy for ascending colon cancer. Tech Coloproctol, 2020, 24(11): 1207-1211.

1. Heald RJ. A new solution to some old problems: transanal TME. Tech Coloproctol, 2013, 17(3): 257-258.
2. Sylla P, Rattner DW, Delgado S, et al. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc, 2010, 24(5): 1205-1210.
3. de Lacy FB, van Laarhoven JJEM, Pena R, et al. Transanal total mesorectal excision: pathological results of 186 patients with mid and low rectal cancer. Surg Endosc, 2018, 32(5): 2442-2447.
4. Aubert M, Mege D, Panis Y. Total mesorectal excision for low and middle rectal cancer: laparoscopic versus transanal approach-a meta-analysis. Surg Endosc, 2020, 34(9): 3908-3919.
5. D’Andrea AP, McLemore EC, Bonaccorso A, et al. Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve. Surg Endosc, 2020, 34(9): 4101-4109.
6. Gardner IH, Kelley KA, Abdelmoaty WF, et al. Transanal total mesorectal excision outcomes for advanced rectal cancer in a complex surgical population. Surg Endosc, 2022, 36(1): 167-175.
7. Liu H, Zeng Z, Zhang H, et al. Morbidity, Mortality, and pathologic outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer short-term outcomes from a multicenter randomized controlled trial. Ann Surg, 2023, 277(1): 1-6.
8. Benson AB, Venook AP, Al-Hawary MM, et al. Rectal Cancer, Version 2. 2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 2022, 20(10): 1139-1167.
9. Buess G, Kipfmüller K, Ibald R, et al. Clinical results of transanal endoscopic microsurgery. Surg Endosc, 1988, 2(4): 245-250.
10. Guerrieri M, Baldarelli M, de Sanctis A, et al. Treatment of rectal adenomas by transanal endoscopic microsurgery: 15 years' experience. Surg Endosc, 2010, 24(2): 445-449.
11. Junginger T, Goenner U, Hitzler M, et al. Long-term oncologic outcome after transanal endoscopic microsurgery for rectal carcinoma. Dis Colon Rectum, 2016, 59(1): 8-15.
12. Serra-Aracil X, Flores-Clotet R, Mora-López L, et al. Transanal endoscopic microsurgery in very large and ultra large rectal neoplasia. Tech Coloproctol, 2019, 23(9): 869-876.
13. Khoury R, Duek SD, Issa N, et al. Transanal endoscopic microsurgery for large benign rectal tumors; where are the limits? Int J Surg, 2016, 29: 128-131.
14. Atallah S, Larach SW. Transanal minimally invasive surgery. JAMA Surg, 2021, 156(1): 92-93.
15. Lee L, Burke JP, deBeche-Adams T, et al. Transanal minimally invasive surgery for local excision of benign and malignant rectal neoplasia: outcomes from 200 consecutive cases with midterm follow up. Ann Surg, 2018, 267(5): 910-916.
16. Lee L, Edwards K, Hunter IA, et al. Quality of local excision for rectal neoplasms using transanal endoscopic microsurgery versus transanal minimally invasive surgery: A multi-institutional matched analysis. Dis Colon Rectum, 2017, 60(9): 928-935.
17. Stipa F, Tierno SM, Russo G, et al. Trans-anal minimally invasive surgery (TAMIS) versus trans-anal endoscopic microsurgery (TEM): a comparative case-control matched-pairs analysis. Surg Endosc, 2022, 36(3): 2081-2086.
18. Van den Eynde F, Jaekers J, Fieuws S, et al. TAMIS is a valuable alternative to TEM for resection of intraluminal rectal tumors. Tech Coloproctol, 2019, 23(2): 161-166.
19. Rindi G, Mete O, Uccella S, et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol, 2022, 33(1): 115-154.
20. Shi WK, Hou R, Li YH, et al. Long-term outcomes of transanal endoscopic microsurgery for the treatment of rectal neuroendocrine tumors. BMC Surg, 2022, 22(1): 43.
21. Lie JJ, Yoon HM, Karimuddin AA, et al. Management of rectal neuroendocrine tumours by transanal endoscopic microsurgery. Colorectal Dis, 2023, 25(5): 1026-1035.
22. Park SS, Kim BC, Lee DE, et al. Comparison of endoscopic submucosal dissection and transanal endoscopic microsurgery for T1 rectal neuroendocrine tumors: a propensity score-matched study. Gastrointest Endosc, 2021, 94(2): 408-415.
23. Hayashi S, Takayama T, Ikarashi M, et al. Transanal minimally invasive surgery for rectal neuroendocrine tumors. Surg Endosc, 2021, 35(12): 6746-6753.
24. Kameyama H, Kanda T, Tajima Y, et al. Management of rectal gastrointestinal stromal tumor. Transl Gastroenterol Hepatol, 2018, 3: 8.
25. Bai X, Zhou W, Li Y, et al. Transanal endoscopic microsurgery with alternative neoadjuvant imatinib for localized rectal gastrointestinal stromal tumor: a single center experience with long-term surveillance. Surg Endosc, 2021, 35(7): 3607-3617.
26. Punnen S, Karimuddin AA, Raval MJ, et al. Transanal endoscopic microsurgery (TEM) for rectal GI stromal tumor. Am J Surg, 2021, 221(1): 183-186.
27. Yang Z, Guo W, Huang R, et al. Transanal versus nontransanal surgery for the treatment of primary rectal gastrointestinal stromal tumors: a 10-year experience in a high-volume center. Ann Transl Med, 2020, 8(5): 201.
28. Spinelli A, Carvello M, Sacchi M, et al. Transanal minimally invasive surgery (TAMIS) for anterior rectal GIST. Tech Coloproctol, 2019, 23(5): 501-502.
29. Kato K, Saito T, Matsuda M, et al. Successful treatment of a rectal anastomotic stenosis by transanal endoscopic microsurgery (TEM) using the contact Nd: YAG laser. Surg Endosc, 1997, 11(5): 485-487.
30. D’Ambrosio G, Lamazza A, Palma R, et al. Transanal endoscopic microsurgery: endoscopy assisted treatment of colorectal anastomotic stenosis. Ann Coloproctol, 2020, 36(4): 285-288.
31. Valdés-Hernández J, Del Rio FJ, Gómez-Rosado JC, et al. TAMIS repair of a rectal stenosis not treatable by endoscopy. Tech Coloproctol, 2018, 22(11): 891.
32. Dapri G, Van Gossum M, Muls V, et al. Transanal endo-laparoscopic circumferential mucosectomy for symptomatic benign rectal stenosis—a video vignette. Colorectal Dis, 2017, 19(2): 210-211.
33. Zhou W, Xia L, Wang Z, et al. Transanal minimally invasive surgery for rectal anastomotic stenosis after colorectal cancer surgery. Dis Colon Rectum, 2022, 65(8): 1062-1068.
34. Luo S, Zhang X, Hou Y, et al. Transanal and transabdominal combined endoscopic resection of rectal stenosis and anal reconstruction based on transanal endoscopic technique. Surg Endosc, 2021, 35(12): 6827-6835.
35. Wang HT, Gao XH, Fu CG, et al. Diagnosis and treatment of diffuse cavernous hemangioma of the rectum: report of 17 cases. World J Surg, 2010, 34(10): 2477-2486.
36. Wang HT, Tu Y, Fu CG, et al. Diffuse cavernous hemangioma of the rectosigmoid colon. Tech Coloproctol, 2005, 9(2): 145-148.
37. Yorozuya K, Watanabe M, Hasegawa H, et al. Diffuse cavernous hemangioma of the rectum: report of a case. Surg Today, 2003, 33(4): 309-311.
38. Londono-Schimmer EE, Ritchie JK, Hawley PR. Coloanal sleeve anastomosis in the treatment of diffuse cavernous haemangioma of the rectum: long-term results. Br J Surg, 1994, 81(8): 1235-1237.
39. Wu XR, Liang WW, Zhang XW, et al. Transanal total mesorectal excision as a surgical procedure for diffuse cavernous hemangioma of the rectum: A case report. Int J Surg Case Rep, 2017, 39: 164-167.
40. Zeng Z, Wu X, Chen J, et al. Safety and feasibility of transanal endoscopic surgery for diffuse cavernous hemangioma of the rectum. Gastroenterol Res Pract, 2019, 2019: 1732340.
41. Truong A, Wood T, Fleshner PR, et al. A single-center experience of transanal proctectomy with IPAA for IBD. Dis Colon Rectum, 2022, 65(9): 1121-1128.
42. de Buck van Overstraeten A, Mark-Christensen A, Wasmann KA, et al. Transanal versus transabdominal minimally invasive (completion) proctectomy with ileal pouch-anal anastomosis in ulcerative colitis: A comparative study. Ann Surg, 2017, 266(5): 878-883.
43. 中国医师协会内镜医师分会腹腔镜外科专业委员会, 中国医师协会结直肠肿瘤专业委员会腹腔镜专业委员会, 中华医学会外科学分会结直肠外科学组. 中国直肠癌侧方淋巴结转移诊疗专家共识(2019版). 中华胃肠外科杂志, 2019, 22(10): 901-912.
44. Ogura A, Konishi T, Cunningham C, et al. Neoadjuvant (Chemo) radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: Results of the multicenter lateral node study of patients with low cT3/4 rectal cancer. J Clin Oncol, 2019, 37(1): 33-43.
45. Aiba T, Uehara K, Mukai T, et al. Transanal extended rectal surgery with lateral pelvic lymph node dissection. Tech Coloproctol, 2018, 22(11): 893-894.
46. Matsuda T, Yamashita K, Hasegawa H, et al. Two-team lateral pelvic lymph node dissection assisted by the transanal approach. Dis Colon Rectum, 2021, 64(12): e719-e724.
47. 曾子威, 张兴伟, 陈俊辑, 等. 经肛入路侧方淋巴结清扫手术治疗中低位直肠癌五例. 中华胃肠外科杂志, 2019, 22(8): 781-785.
48. Kimura K, Ikeda M, Kataoka K, et al. Sacrectomy for recurrent rectal cancer using the transanal total mesorectum excision technique. Dis Colon Rectum, 2020, 63(12): e566-e573.
49. Huang L, Zhang X, Zeng Z, et al. Pure transanal endoscopic colectomy for ascending colon cancer. Tech Coloproctol, 2020, 24(11): 1207-1211.

Previous Article
Treatment strategy for the obstructive or perforated rectal cancer
Next Article
Prevention of complications following pelvic exenteration

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Application in addition to total mesorectal excision of transanal endoscopic surgery approach

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content